Impaired gastrointestinal transit and its associated morbidity in the intensive care unit

Journal of Critical Care

Volumn 28, Issue 4, 2013, Pages 537.e11-537.e17

  Nguyen, Tiffany ^a   Frenette, Anne Julie ^b   Johanson, Christel ^a   MacLean, Robert D ^a   Patel, Rakesh ^a   Simpson, Allison ^a   Singh, Avinder ^a   Balchin, Katelyn S ^c   Fergusson, Dean ^c   Kanji, Salmaan ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Bowel; Constipation; Critical illness; Gastrointestinal disease; Ileus; Intensive care unit

Indexed keywords

17 METHYLNALTREXONE; BISACODYL; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCEROL; LACTULOSE; MACROGOL 3350; MAGNESIUM HYDROXIDE; MINERAL OIL; NALOXONE; NARCOTIC ANALGESIC AGENT; SODIUM DIHYDROGEN PHOSPHATE;

ABDOMINAL DISTENSION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONSTIPATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIGESTIVE SYSTEM FUNCTION DISORDER; ENTERIC FEEDING; FEMALE; GASTRIC DYSMOTILITY; HUMAN; ILEUS; IMPAIRED GASTROINTESTINAL TRANSIT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; NUTRITIONAL INTOLERANCE; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; APACHE; CHI SQUARE DISTRIBUTION; CRITICAL ILLNESS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRANSIT; INTENSIVE CARE UNIT; INTESTINE; MIDDLE AGED; MULTICENTER STUDY; REGRESSION ANALYSIS; RISK FACTOR;

BOWEL; CONSTIPATION; CRITICAL ILLNESS; GASTROINTESTINAL DISEASE; ILEUS; INTENSIVE CARE UNIT;

APACHE; CHI-SQUARE DISTRIBUTION; CONSTIPATION; CRITICAL ILLNESS; ENTERAL NUTRITION; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; ILEUS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 84886697760     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.12.003     Document Type: Article

References (31)

1. Ukleja A. Altered GI, motility in critically Ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach. Nutr Clin Pract 2010, 25:16-25.
2. Dorman B.P., Hill C., McGrath M., et al. Bowel management in the intensive care unit. Intensive Crit Care Nurs 2004, 20:320-329.
3. Btaiche I.F., Chan L.N., Pleva M., Kraft M.D. Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients. Nutr Clin Pract 2010, 25:32-49.
4. Rohm K.D., Boldt J., Piper S.N. Motility disorders in the ICU: recent therapeutic options and clinical practice. Curr Opin Clin Nutr Metab Care 2009, 12:161-167.
5. Fraser R.J., Bryant L. Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient. Nutr Clin Pract 2010, 25:26-31.
6. Kurz A., Sessler D.I. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003, 63:649-671.
7. Artinyan A., Nunoo-Mensah J.W., Balasubramaniam S., et al. Prolonged postoperative ileus-definition, risk factors, and predictors after surgery. World J Surg 2008, 32:1495-1500.
8. Gacouin A., Camus C., Gros A., et al. Constipation in long-term ventilated patients: associated factors and impact on intensive care unit outcomes. Crit Care Med 2010, 38:1933-1938.
9. Nassar A.P., da Silva F.M., de Cleva R. Constipation in intensive care unit: incidence and risk factors. J Crit Care 2009, 24:630e9-630e12.
10. Mostafa S.M., Bhandari S., Ritchie G., Gratton N., Wenstone R. Constipation and its implications in the critically ill patient. Br J Anaesth 2003, 91:815-819.
11. Herbert M.K., Holzer P. Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients-current status and future options. Clin Nutr 2008, 27:25-41.
12. Ramkumar D., Rao S.S. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005, 100:936-971.
13. van der Spoel J.I., Oudemans-van Straaten H.M., Stoutenbeek C.P., Bosman R.J., Zandstra D.F. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure-a prospective, double-blind, placebo-controlled trial. Intensive Care Med 2001, 27:822-827.
14. Thomas J., Karver S., Cooney G.A., et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008, 358:2332-2343.
15. Taguchi A., Sharma N., Saleem R.M., et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001, 345:935-940.
16. Slatkin N., Thomas J., Lipman A.G., et al. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 2009, 7:39-46.
17. Portenoy R.K., Thomas J., Moehl Boatwright M.L., et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 2008, 35:458-468.
18. Norwood M.G., Lykostratis H., Garcea G., Berry D.P. Acute colonic pseudo-obstruction following major orthopaedic surgery. Colorectal Dis 2005, 7:496-499.
19. Nelson J.D., Urban J.A., Salsbury T.L., Lowry J.K., Garvin K.L. Acute colonic pseudo-obstruction (Ogilvie syndrome) after arthroplasty in the lower extremity. J Bone Joint Surg Am 2006, 88:604-610.
20. Ludwig K., Enker W.E., Delaney C.P., et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg 2008, 143:1098-1105.
21. Goettsch W.G., Sukel M.P., van der Peet D.L., van Riemsdijk M.M., Herings R.M. In-hospital use of opioids increases rate of coded postoperative paralytic ileus. Pharmacoepidemiol Drug Saf 2007, 16:668-674.
22. Thibault R., Pichard C. Nutrition and clinical outcome in intensive care patients. Curr Opin Clin Nutr Metab Care 2010, 13:177-183.
23. Singer P., Pichard C., Heidegger C.P., Wernerman J. Considering energy deficit in the intensive care unit. Curr Opin Clin Nutr Metab Care 2010, 13:170-176.
24. Villet S., Chiolero R.L., Bollmann M.D., et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 2005, 24:502-509.
25. Taylor S.J., Fettes S.B., Jewkes C., Nelson R.J. Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury. Crit Care Med 1999, 27:2525-2531.
26. Rubinson L., Diette G.B., Song X., Brower R.G., Krishnan J.A. Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Crit Care Med 2004, 32:350-357.
27. Martin C.M., Doig G.S., Heyland D.K., Morrison T., Sibbald W.J. Southwestern Ontario Critical Care Research N. Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ 2004, 170:197-204.
28. Faisy C., Lerolle N., Dachraoui F., et al. Impact of energy deficit calculated by a predictive method on outcome in medical patients requiring prolonged acute mechanical ventilation. Br J Nutr 2009, 101:1079-1087.
29. Alberda C., Gramlich L., Jones N., et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 2009, 35:1728-1737.
30. Casaer M.P., Mesotten D., Hermans G., et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517.
31. Barletta J.F., Asgeirsson T., Senagore A.J. Influence of intravenous opioid dose on postoperative ileus. Ann Pharmacother 2011, 45:916-923.